CD163 and type 2 diabetes mellitus: Our findings suggest that those with higher serum n-3 PUFAs at baseline have a significantly altered levels of AT inflammatory biomarkers (higher sCD163 and lower adiponectin) in the following years in a Canadian population at risk for T2D.